Ligand Pharmaceuticals Inc To Host Investor and Analyst Day Transcript - Thomson StreetEvents

Ligand Pharmaceuticals Inc To Host Investor and Analyst Day Transcript

Ligand Pharmaceuticals Inc To Host Investor and Analyst Day Transcript - Thomson StreetEvents
Ligand Pharmaceuticals Inc To Host Investor and Analyst Day Transcript
Published Dec 10, 2024
23 pages (15624 words) — Published Dec 10, 2024
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of LGND.OQ corporate analyst meeting

  
Brief Excerpt:

...Thank you, Melanie, appreciate that. As we begin today, I would just like to introduce a few people in the room. We have four of our Board members in the front row here: Dr. John LaMattina, Dr. John Kozarich, Dr. Martine Zimmerman, and Dr. Steve Sabba. We do have a lot of prowess on the Board. We're going to begin today with a quiz. Which of these two Board members were roommates in college? Yeah, you guessed it, the two gentlemen on the right, my right....

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Ligand Pharmaceuticals Inc
Ticker
LGND.OQ
Time
3:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Joseph Pantginis - H. C. Wainwright & Co., LLC - Analyst : Thank you, everybody, for the details. Joe Pantginis from H. C. Wainwright. So first, a broader question for Todd and the team. While volatile, the equity markets for health care have been stabilizing a bit and somewhat improving, again, though volatile. How has that impacted your potential deal flow and creativity? And then I have a follow-up.

Question: Joseph Pantginis - H. C. Wainwright & Co., LLC - Analyst : Got it. And then maybe just a quick follow-up for Karen with regard to Captisol. You mentioned a backup facility. Is that an internal facility? I don't think so.

Question: Joseph Pantginis - H. C. Wainwright & Co., LLC - Analyst : But it's more of your external?

Question: Joseph Pantginis - H. C. Wainwright & Co., LLC - Analyst : And do you have any potential projections for you or the company about when you might need that facility to come online? And what kind of capacity does it give to you?

Question: Joseph Pantginis - H. C. Wainwright & Co., LLC - Analyst : (inaudible)

Table Of Contents

Ligand Pharmaceuticals Inc To Host Investor Day Transcript – 2025-12-09 – US$ 54.00 – Edited Transcript of LGND.OQ corporate analyst meeting</ 9-Dec-25 3:30pm GMT

Ligand Pharmaceuticals Inc Q3 2025 Earnings Call Transcript – 2025-11-06 – US$ 54.00 – Edited Transcript of LGND.OQ earnings conference call or presentation 6-Nov-25 1:30pm GMT

Ligand Pharmaceuticals Inc Q2 2025 Earnings Call Transcript – 2025-08-07 – US$ 54.00 – Edited Transcript of LGND.OQ earnings conference call or presentation 7-Aug-25 12:30pm GMT

Ligand Pharmaceuticals Inc Q1 2025 Earnings Call Transcript – 2025-05-08 – US$ 54.00 – Edited Transcript of LGND.OQ earnings conference call or presentation 8-May-25 12:30pm GMT

Ligand Pharmaceuticals Inc Q4 2024 Earnings Call Transcript – 2025-02-27 – US$ 54.00 – Edited Transcript of LGND.OQ earnings conference call or presentation 27-Feb-25 1:30pm GMT

Ligand Pharmaceuticals Inc Q3 2024 Earnings Call Transcript – 2024-11-07 – US$ 54.00 – Edited Transcript of LGND.OQ earnings conference call or presentation 7-Nov-24 1:30pm GMT

Ligand Pharmaceuticals Inc Q2 2024 Earnings Call Transcript – 2024-08-06 – US$ 54.00 – Edited Transcript of LGND.OQ earnings conference call or presentation 6-Aug-24 8:30pm GMT

Ligand Pharmaceuticals Inc Annual Shareholders Meeting Transcript – 2024-06-14 – US$ 54.00 – Edited Transcript of LGND.OQ shareholder or annual meeting 14-Jun-24 3:30pm GMT

Ligand Pharmaceuticals Inc To Host Investor Day Transcript – 2023-12-12 – US$ 54.00 – Edited Transcript of LGND.OQ corporate analyst meeting</ 12-Dec-23 3:30pm GMT

Ligand Pharmaceuticals Inc Q3 2023 Earnings Call Transcript – 2023-11-08 – US$ 54.00 – Edited Transcript of LGND.OQ earnings conference call or presentation 8-Nov-23 9:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Ligand Pharmaceuticals Inc To Host Investor and Analyst Day Transcript" Dec 10, 2024. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Ligand-Pharmaceuticals-Inc-To-Host-Investor-and-Analyst-Day-T16167287>
  
APA:
Thomson StreetEvents. (2024). Ligand Pharmaceuticals Inc To Host Investor and Analyst Day Transcript Dec 10, 2024. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Ligand-Pharmaceuticals-Inc-To-Host-Investor-and-Analyst-Day-T16167287>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.